Clinical Trial Update: A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer [NA]

View source ↗

Summary

A multicenter study is assessing how well the PET/CT tracer 68Ga-MY6349 detects prostate cancer, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-MY6349 PET/CT (68Ga-MY6349)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Positron-Emission Tomography(PET), Prostate Cancer | NA | Status: RECRUITING